South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant
Sept. 22, 2022 South Rampart Pharma ("South Rampart" or the
Sept. 22, 2022 South Rampart Pharma ("South Rampart" or the
Aug. 25, 2022 South Rampart Pharma ("South Rampart" or the
Aug. 16, 2022 South Rampart Pharma ("South Rampart" or the
May 4, 2022 $1.9 million NIH fast-track STTR grant fuels
March 23, 2022 SRP-3D (DA) has demonstrated a compelling safety
Sep 25, 2020 The National Institute of Neurological Disorders and
July 10, 2020 South Rampart Pharma, LLC (“South Rampart” or
Jul 6, 2020 Researchers at LSU Health New Orleans Neuroscience